Molecular Design of Conjugated Small Molecule Nanoparticles for Synergistically Enhanced PTT/PDT.
Ontology highlight
ABSTRACT: Simultaneous photothermal therapy (PTT) and photodynamic therapy (PDT) is beneficial for enhanced cancer therapy due to the synergistic effect. Conventional materials developed for synergistic PTT/PDT are generally multicomponent agents that need complicated preparation procedures and be activated by multiple laser sources. The emerging monocomponent diketopyrrolopyrrole (DPP)-based conjugated small molecular agents enable dual PTT/PDT under a single laser irradiation, but suffer from low singlet oxygen quantum yield, which severely restricts the therapeutic efficacy. Herein, we report acceptor-oriented molecular design of a donor-acceptor-donor (D-A-D) conjugated small molecule (IID-ThTPA)-based phototheranostic agent, with isoindigo (IID) as selective acceptor and triphenylamine (TPA) as
SUBMITTER: Shao W
PROVIDER: S-EPMC7770699 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA